Page last updated: 2024-10-18

dihydroxyacetone and Porphyrias, Hepatic

dihydroxyacetone has been researched along with Porphyrias, Hepatic in 1 studies

Porphyrias, Hepatic: A group of metabolic diseases due to deficiency of one of a number of LIVER enzymes in the biosynthetic pathway of HEME. They are characterized by the accumulation and increased excretion of PORPHYRINS or its precursors. Clinical features include neurological symptoms (PORPHYRIA, ACUTE INTERMITTENT), cutaneous lesions due to photosensitivity (PORPHYRIA CUTANEA TARDA), or both (HEREDITARY COPROPORPHYRIA). Hepatic porphyrias can be hereditary or acquired as a result of toxicity to the hepatic tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asawanonda, P1
Oberlender, S1
Taylor, C1

Other Studies

1 other study available for dihydroxyacetone and Porphyrias, Hepatic

ArticleYear
The use of dihydroxyacetone for photoprotection in variegate porphyria.
    International journal of dermatology, 1999, Volume: 38, Issue:12

    Topics: Adult; Dihydroxyacetone; Female; Humans; Porphyrias, Hepatic; Skin; Sunscreening Agents

1999